Cultivation and production of medical cannabis

Thomas Skovlund Schnegelsberg, CEO STENOCARE
Our company purpose is to help create more better days for patients, using our pharma-based mentality for medical cannabis production Thomas Skovlund Schnegelsberg, CEO STENOCARE

STENOCARE is a Danish company that cultivate, produce, import and sell prescription-based medical cannabis.

The company was founded in 2017 with the sole purpose of being an active participant in the Danish medical cannabis pilot programme. The company has received the Danish Medicines Agency’s licenses to cultivate and produce medical cannabis, and to import and distribute medical cannabis to Danish patients.

STENOCARE executive management
Hygiene around the plants is important to ensure optimum quality. Photo of STENOCARE’s management.

STENOCARE cultivate and produce medical cannabis plants in high-tech indoor climate rooms, where it is possible to control all the conditions that affect the strength, quality and uniformity of the plants. The rooms are insulated so that sunlight, outdoor air and harmful living organisms cannot affect cultivation.

STENOCARE has partnered with Emerald Health Therapeutics, a leading medical cannabis manufacturer, for the purpose of importing their finished products into Denmark. STENOCARE wishes to work with several suppliers to achieve better security of supply and to give patients the possibility to choose between more types of products for their medical cannabis treatment.


STENOCAREs vision is to provide high quality medical cannabis that gives patients better quality of life.

STENOCARE mission and vision


STENOCAREs mission is to provide uniform medical cannabis products grown and produced in hygienic climate rooms without the use of pesticides.

STENOCARE has its headquarter in Denmark with two different locations. The main location is in Jutland, where the cultivation facility and production activities take place.

STENOCARE location: Jutland
STENOCARE location: Zealand